Belgium Denmark Finland France Germany Iberia Italy Netherlands Norway Sweden UK
Interim Results 2008 Belgium Denmark Finland France - - PowerPoint PPT Presentation
Interim Results 2008 Belgium Denmark Finland France - - PowerPoint PPT Presentation
Interim Results 2008 Belgium Denmark Finland France Germany Iberia Italy Netherlands Norway Sweden UK Richard Moon Chairman 2 Belgium Denmark Finland France Germany
Belgium Denmark Finland France Germany Iberia Italy Netherlands Norway Sweden UK
2
Richard Moon Chairman
Belgium Denmark Finland France Germany Iberia Italy Netherlands Norway Sweden UK
3
Agenda Chairman – Introduction and Overview Finance Director – Financial review Executive Directors – Q&A
Belgium Denmark Finland France Germany Iberia Italy Netherlands Norway Sweden UK
4
Overview
Restructured Board, new Chief Executive Net cash of £16.9 million Post half-year end consideration of £16.2 million from sale of MessageLabs Group - £15.1 million received November 2008 subject to tax at 28% Sales resilient, margins under pressure Rebased interim dividend of 3.5 pence per share Impairments Westech, goodwill
Belgium Denmark Finland France Germany Iberia Italy Netherlands Norway Sweden UK
5
Management Team
Nick Jefferies Chief Executive Officer Malcolm Cooper Finance Director Stephen Sydes Electronics Divisional MD
Belgium Denmark Finland France Germany Iberia Italy Netherlands Norway Sweden UK
6
Malcolm Cooper Financial review
Belgium Denmark Finland France Germany Iberia Italy Netherlands Norway Sweden UK
7
Westech Electronics
- Associate listed on Singapore stock exchange
- $35 million bad debt - 54% of trade receivables
- Attempting to negotiate standstill arrangement
- Balance sheet value £5.0 million at September 2008
- Goodwill associated with investment £0.03m
- Investment fully impaired and disclosed as an exceptional item
in half year results
Belgium Denmark Finland France Germany Iberia Italy Netherlands Norway Sweden UK
8
MessageLabs Group (MLG)
- 3.95% investment held at cost - £0.3 million
- Sale to Symantec completed November 2008 for c £400 million
- £15.1million received 14 November 2008
- £1.15m held in escrow against warranty claims
- Gain subject to tax at prevailing rate of 28%
- Disclosed as post balance sheet event
Belgium Denmark Finland France Germany Iberia Italy Netherlands Norway Sweden UK
9
Exceptional Items
£m Write back of unutilised provision for retained
- bligations
0.8 Costs of termination of Board Director contracts (0.8) Impairment of goodwill (4.2) Impairment of associate investment (5.0) Exceptional Items (9.2)
Belgium Denmark Finland France Germany Iberia Italy Netherlands Norway Sweden UK
10
Interim results
Continuing operations Half year to 30 September Year to 31 March £m 2008 2007 2008 Sales 79.8 77.6 159.5 Operating profit 1.0 2.8 6.1 Associates (post-tax)
- 0.5
0.7 Net finance revenue/(cost) 0.2 (0.7) (0.8) Profit before exceptional items 1.2 2.6 6.1 Exceptional items (9.2)
- (3.5)
(Loss)/profit before tax - continuing
- perations
(8.0) 2.6 2.6 (Loss)/profit after tax (8.0) 1.8 0.5 Basic earnings per share excluding exceptional items 2.4p 6.7p 14.5p Dividends per share relating to period 3.5p 7.2p 21.9p
Belgium Denmark Finland France Germany Iberia Italy Netherlands Norway Sweden UK
11
Divisional results
£m
30-Sep-08 30-Sep-07 31-Mar-08
Electronics 51.3 50.1 103.1 Parts 25.1 23.9 48.3 Medical & Scientific 3.4 3.6 8.1 Revenue 79.8 77.6 159.5 Electronics 1.4 1.7 3.2 Parts 0.5 1.7 3.3 Medical & Scientific 0.5 0.6 1.3 Unallocated Costs (1.4) (1.2) (1.7) Operating Profit 1.0 2.8 6.1
Belgium Denmark Finland France Germany Iberia Italy Netherlands Norway Sweden UK
12
Change in revenue
2007 70.0 72.0 74.0 76.0 78.0 80.0 82.0 84.0 2007 Exchange Rates Electronics Parts Scientific & Medical 2008
Belgium Denmark Finland France Germany Iberia Italy Netherlands Norway Sweden UK
13
Change in Operating Profit
Exchange Rates Electronics Parts Medical & ScientificHead Office 2008 £2.8m
- 0.5
1.0 1.5 2.0 2.5 3.0 2007 Exchange Rates Electronics Parts Medical & Scientific Head Office 2008
- 0.5
1.0 1.5 2.0 2.5 3.0 2007 Exchange Rates Electronics Parts Medical & Scientific Head Office 2008
Belgium Denmark Finland France Germany Iberia Italy Netherlands Norway Sweden UK
14
Income Statement highlights
Gross Margin
- Decrease from 29.7% to 27.2% for half year
- Reflects margin pressure in Electronics & Parts Services divisions
Overheads (excluding exceptional items)
- Net Operating Expenses £20.7m compared to £20.3m last year
- Electronics employees reduced from 379 to 348 over half year
- Electronics centralisation largely complete
- Parts Services employee numbers stable
- Continuing focus on controlling overheads
Taxation (ongoing activities excluding associates)
- Effective Tax Rate of 45.3% compared to 38.9% last year
- Rate affected by unrelieved losses in Continental Europe
Belgium Denmark Finland France Germany Iberia Italy Netherlands Norway Sweden UK
15
Balance Sheet Highlights
30 September 31 March 2008 2007 2008
Equity Shareholders’ Funds £89.3m £75.2m £100.7m Net Cash/(Debt) £16.9m £(11.1)m £25.6m
- Reduction in shareholders’ funds:
Impairment of Associate investment £(5.0) million, Impairment of goodwill £(4.2) million Dividend £(3.9) million
- Excludes valuation of MessageLabs Group – additional £15.9 million
- IAS 19 pension liability £3.3m (March 2008: £3.8m) reflects contributions paid
Triennial actuarial valuation March 2009
Belgium Denmark Finland France Germany Iberia Italy Netherlands Norway Sweden UK
16
Net trading assets
Continuing operations 30 Sept 2008 31 March 2008 30 Sept 2007 Current Assets Stock Debtors 23.0 36.5 19.3 36.0 18.8 28.2 Current Liabilities Creditors (35.0) (34.2) (23.2) Net Trading Assets 24.5 21.1 23.8
Belgium Denmark Finland France Germany Iberia Italy Netherlands Norway Sweden UK
17
Consolidated cash flow
£m Half year to 30 September Year to 31 March 2008 2007 2008 Cash (expended)/generated from
- perations
(2.9) 0.9 6.7 Capital expenditure less disposals (0.7) (0.3) (0.9) Proceeds from sale of businesses
- 38.5
Tax (1.6) (1.7) (5.7) Interest 0.2 (0.8) (1.2) Dividends paid (3.9) (3.9) (5.8) Other 0.2 (0.1) (0.8) Net cash (outflow)/inflow (8.7) (5.7) 31.0 Net Cash/(Debt) at period end 16.9 (11.1) 25.6 Net cash increased by Message Labs proceeds of £15.1 m in November 2008 Cash flows include disposed activities
Belgium Denmark Finland France Germany Iberia Italy Netherlands Norway Sweden UK
18
Cash generated from operations
£m Half year to 30 September Year to 31 March 2008 2007 2008 Operating profit – continuing – disposed 1.0
- 2.8
1.9 2.6 2.0 Depreciation and amortisation 0.9 1.3 4.6 Increase in working capital (2.9) (4.3) (1.4) Pension scheme funding (0.6) (0.6) (1.6) Movement in provisions (1.3) (0.3) 0.3 Other
- 0.1
0.2 Cash generated from operations (2.9) 0.9 6.7 Net Cash/(Debt) at period end 16.9 (11.1) 25.6
Prior period cash flows include disposed activities
Belgium Denmark Finland France Germany Iberia Italy Netherlands Norway Sweden UK
19
Businesses
Belgium Denmark Finland France Germany Iberia Italy Netherlands Norway Sweden UK
20
Acal’s Businesses
Electronics
Design in and Production fulfilment of a range of complementary technology products comprising semiconductors, power solutions, system components (boards and assemblies), microwave & wireless devices, passive, timing/frequency control and electromechanical components
Parts Services
Supply and management of parts primarily for the IT industry, product support for service organisations and third party maintenance companies servicing PC’s, printers, servers, mainframes , ATM’s and EPOS
Medical & Scientific
Vertec Scientific is a supplier of medical and scientific equipment to the healthcare marketplace including as the UK's No.1 supplier of Osteoporosis Diagnosis equipment (DEXA scanners) as well as the UK's largest supplier of mini surgical c-arms
Belgium Denmark Finland France Germany Iberia Italy Netherlands Norway Sweden UK
21
Electronics
Sales £m
2007 2008 2007 2008
50.1
Half Year to 30 September
- Market weak, volatile, no consistency in industry forecasts
- Increasing market share, product profile developing
- Organisational changes in Germany & Nordic showing positive
results
- Benelux, France suffering this year
- Margin pressure through mix changes, exchange rate volatility &
supplier policy changes
- Centralisation of support functions completed, overhead
reduction programme executed
EBIT % of Sales: 3.4% 2.7% Change: 2.4% 1.7 51.3 1.4
EBIT £m
Belgium Denmark Finland France Germany Iberia Italy Netherlands Norway Sweden UK
22
Parts Services
Half Year to 30 September
Sales £m
2008
23.9 25.1
2007
- Weak demand and pricing pressures have led to year-on-year
reduction in sales and margins from existing business
- Costs associated with major new contract started in May 2008
higher than anticipated
- Actively progressing initiatives to enhance division’s performance
Change: 5.0%
EBIT £m
2007 2008
1.7
EBIT % of Sales: 5.2% 5.9%
0.5
Belgium Denmark Finland France Germany Iberia Italy Netherlands Norway Sweden UK
23
Medical & Scientific
Half Year to 30 September
Sales £m
2008
3.6 3.4
2007
- A very well established supplier to the UK and recently South
African healthcare marketplace
- Economic downturn has affected the business, but to a lesser
extent than many competitors
- Margins have remained stable
- South African focus moving to the public sector, as the private
marketplace is feeling the impact of the recession.
Change: (5.6)%
EBIT £m
2007 2008
EBIT % of Sales: 16.7% 14.7%
0.5 0.6
Belgium Denmark Finland France Germany Iberia Italy Netherlands Norway Sweden UK
24
Current trading & outlook
Belgium Denmark Finland France Germany Iberia Italy Netherlands Norway Sweden UK
25
Current trading and outlook
- Recent market trauma, exchange & interest rate volatility - difficult to accurately
project short-term performance
- Significant strain on electronics margins in short-term due to exchange rate
movements
- Parts Services sales/margins remain under pressure
- Vertec business maintaining sound performance
- Businesses prepared for more difficult trading conditions
- Strong cash position provides opportunity for selective acquisition opportunities
that may present themselves